Masaki Otagiri

22.3k total citations · 3 hit papers
601 papers, 18.7k citations indexed

About

Masaki Otagiri is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Masaki Otagiri has authored 601 papers receiving a total of 18.7k indexed citations (citations by other indexed papers that have themselves been cited), including 301 papers in Molecular Biology, 112 papers in Oncology and 98 papers in Cell Biology. Recurrent topics in Masaki Otagiri's work include Protein Interaction Studies and Fluorescence Analysis (169 papers), Drug Transport and Resistance Mechanisms (96 papers) and Drug Solubulity and Delivery Systems (77 papers). Masaki Otagiri is often cited by papers focused on Protein Interaction Studies and Fluorescence Analysis (169 papers), Drug Transport and Resistance Mechanisms (96 papers) and Drug Solubulity and Delivery Systems (77 papers). Masaki Otagiri collaborates with scholars based in Japan, Australia and Denmark. Masaki Otagiri's co-authors include Toru Maruyama, Victor Tuan Giam Chuang, Ulrich Kragh‐Hansen, Kaneto Uekama, Teruko Imai, Keishi Yamasaki, Hiroshi Watanabe, Makoto Anraku, Stephen Curry and Ananyo A. Bhattacharya and has published in prestigious journals such as Journal of Biological Chemistry, ACS Nano and PLoS ONE.

In The Last Decade

Masaki Otagiri

589 papers receiving 18.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structural Basis of the Drug-binding Specificity of Human Serum Albumin

2005 1.6k citations Masaki Otagiri, Stephen Curry et al. profile →
Practical Aspects of the Ligand-Binding and Enzymatic Properties of Human Serum Albumin.

2002 774 citations Ulrich Kragh‐Hansen, Victor Tuan Giam Chuang et al. Biological and Pharmaceutical Bulletin profile →
Albumin–drug interaction and its clinical implication

2013 384 citations Keishi Yamasaki, Victor Tuan Giam Chuang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Masaki Otagiri Japan	58	9.7k	3.9k	2.5k	2.3k	2.0k	601	18.7k
Philip D. Ross United States	66	9.1k 0.9×	5.8k 1.5×	377 0.2×	1.0k 0.5×	998 0.5×	217	21.4k
Jan H.M. Schellens Netherlands	91	16.1k 1.7×	22.6k 5.9×	1.2k 0.5×	1.3k 0.6×	938 0.5×	882	41.1k
Yuichi Sugiyama Japan	99	7.8k 0.8×	25.4k 6.6×	1.0k 0.4×	1.2k 0.5×	681 0.3×	831	40.4k
Per Artursson Sweden	84	8.2k 0.9×	7.5k 1.9×	6.4k 2.6×	2.3k 1.0×	355 0.2×	263	23.5k
Michael C. Phillips United States	95	14.8k 1.5×	3.0k 0.8×	260 0.1×	1.0k 0.4×	2.0k 1.0×	292	27.7k
Martin C. Carey United States	61	3.6k 0.4×	4.5k 1.2×	1.0k 0.4×	870 0.4×	446 0.2×	174	13.4k
Guangji Wang China	66	9.3k 1.0×	2.7k 0.7×	505 0.2×	851 0.4×	555 0.3×	692	18.5k
Patrick Augustijns Belgium	73	3.5k 0.4×	3.1k 0.8×	8.8k 3.6×	2.2k 1.0×	123 0.1×	409	18.3k
Alan F. Hofmann United States	84	4.2k 0.4×	11.3k 2.9×	909 0.4×	720 0.3×	1.3k 0.6×	338	23.9k
Ronald P. Mason United States	97	12.4k 1.3×	1.5k 0.4×	191 0.1×	1.3k 0.6×	2.0k 1.0×	659	33.3k

Countries citing papers authored by Masaki Otagiri

Since Specialization

Citations

This map shows the geographic impact of Masaki Otagiri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaki Otagiri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaki Otagiri more than expected).

Fields of papers citing papers by Masaki Otagiri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaki Otagiri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaki Otagiri. The network helps show where Masaki Otagiri may publish in the future.

Co-authorship network of co-authors of Masaki Otagiri

This figure shows the co-authorship network connecting the top 25 collaborators of Masaki Otagiri. A scholar is included among the top collaborators of Masaki Otagiri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaki Otagiri. Masaki Otagiri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yanagisawa, Hiroki, Hitoshi Maeda, Motohiko Tanaka, et al.. (2024). Carbon monoxide-loaded red blood cells ameliorate metabolic dysfunction-associated steatohepatitis progression via enhancing AMP-activated protein kinase activity and inhibiting Kupffer cell activation. Redox Biology. 76. 103314–103314. 4 indexed citations

Taguchi, Kazuaki, Hitoshi Maeda, Yu Ishima, et al.. (2024). Carbon Monoxide Alleviates Post-ischemia–reperfusion Skeletal Muscle Injury and Systemic Inflammation. Biological and Pharmaceutical Bulletin. 47(4). 868–871. 1 indexed citations

Nakamura, Ryota, Kenji Tsukigawa, Koji Nishi, et al.. (2024). Development of α-Cyclodextrin-Based Orally Disintegrating Tablets for 4-Phenylbutyrate. Pharmaceutics. 16(1). 82–82. 4 indexed citations

Nakamura, Ryota, Koji Nishi, Kenji Tsukigawa, et al.. (2023). Study of the Structural Chemistry of the Inclusion Complexation of 4-Phenylbutyrate and Related Compounds with Cyclodextrins in Solution: Differences in Inclusion Mode with Cavity Size Dependency. International Journal of Molecular Sciences. 24(20). 15091–15091. 4 indexed citations

Kinoshita, Ryo, Yu Ishima, Victor Tuan Giam Chuang, et al.. (2021). The Therapeutic Effect of Human Serum Albumin Dimer-Doxorubicin Complex against Human Pancreatic Tumors. Pharmaceutics. 13(8). 1209–1209. 8 indexed citations

Ikeda, Mayumi, Yu Ishima, Victor Tuan Giam Chuang, et al.. (2019). Distribution of Polysulfide in Human Biological Fluids and Their Association with Amylase and Sperm Activities. Molecules. 24(9). 1689–1689. 21 indexed citations

Kadowaki, Daisuke, Shigeyuki Miyamura, Kenichiro Kitamura, et al.. (2018). Benzbromarone Attenuates Oxidative Stress in Angiotensin II‐ and Salt‐Induced Hypertensive Model Rats. Oxidative Medicine and Cellular Longevity. 2018(1). 7635274–7635274. 21 indexed citations

Iohara, Daisuke, Taishi Higashi, Keiichi Motoyama, et al.. (2018). Sacran, a High-molecular Weight Polysaccharide Inhibits Renal Injury and Oxidative Stress in Chronic Renal Failure Model Rats. 4(2). 267–275. 1 indexed citations

Nishi, Koji, Keishi Yamasaki, & Masaki Otagiri. (2017). Interaction of Protizinic Acid with Human Serum Albumin: Site-to-Site Displacement of Protizinic Acid by Ibuprofen. 7(3). 2 indexed citations

10.

Azuma, Kazuo, Ryotaro IZUMI, Yoshiharu Okamoto, et al.. (2016). Biomaterials based on freeze dried surface-deacetylated chitin nanofibers reinforced with sulfobutyl ether β-cyclodextrin gel in wound dressing applications. International Journal of Pharmaceutics. 511(2). 1080–1087. 20 indexed citations

11.

Chuang, Victor Tuan Giam & Masaki Otagiri. (2013). Photoaffinity Labeling of Plasma Proteins. Molecules. 18(11). 13831–13859. 17 indexed citations

12.

Taguchi, Kazuaki, Victor Tuan Giam Chuang, Toru Maruyama, & Masaki Otagiri. (2012). Pharmaceutical Aspects of the Recombinant Human Serum Albumin Dimer: Structural Characteristics, Biological Properties, and Medical Applications. Journal of Pharmaceutical Sciences. 101(9). 3033–3046. 52 indexed citations

13.

Nishi, Koji, Teruya Nakamura, Hiroshi Watanabe, et al.. (2011). Structural Insights into Differences in Drug-binding Selectivity between Two Forms of Human α1-Acid Glycoprotein Genetic Variants, the A and F1*S Forms. Journal of Biological Chemistry. 286(16). 14427–14434. 74 indexed citations

14.

Nagai, Ryoji, Katsumi Mera, Yukio Fujiwara, Mime Nagai, & Masaki Otagiri. (2008). Comparison of Pharmacokinetics between Highly and Mildly Modified AGE Proteins in Mice. Annals of the New York Academy of Sciences. 1126(1). 325–327. 3 indexed citations

15.

Anraku, Makoto, Kenichiro Kitamura, Kazuaki Taguchi, et al.. (2007). An Oral Adsorbent, AST-120 Protects Against the Progression of Oxidative Stress by Reducing the Accumulation of Indoxyl Sulfate in the Systemic Circulation in Renal Failure. Pharmaceutical Research. 24(7). 1283–1289. 101 indexed citations

16.

Ishima, Yu, Takaaki Akaike, Ulrich Kragh‐Hansen, et al.. (2007). Effects of endogenous ligands on the biological role of human serum albumin in S-nitrosylation. Biochemical and Biophysical Research Communications. 364(4). 790–795. 22 indexed citations

17.

Komori, Takafumi, et al.. (1998). Effects of Repeated Clarithromycin Administration on the Pharmacokinetic Properties of Pindolol in Rats.. Biological and Pharmaceutical Bulletin. 21(12). 1376–1378. 3 indexed citations

18.

Rahman, Mohammed Habibur, Toru Maruyama, Tomoko Okada, Keishi Yamasaki, & Masaki Otagiri. (1993). Study of interaction of carprofen and its enantiomers with human serum albumin—I. Biochemical Pharmacology. 46(10). 1721–1731. 194 indexed citations

19.

Harata, Kazuaki, Fumitoshi Hirayama, Teruko Imai, Kaneto Uekama, & Masaki Otagiri. (1984). Crystal structures of permethylated .BETA.-cyclodextrin complexes with R-(-)- and S-(+)-flurbiprofen.. Chemistry Letters. 1549–1552. 3 indexed citations

20.

Otagiri, Masaki & Ushiho Matsumoto. (1980). INTERACTION OF WARFARIN WITH HUMAN SERUM ALBUMIN. Journal of Pharmacobio-Dynamics. 3(9). 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact